Crizotinib Pfizer 200 mg Capsules, hard Tanzania - English - Tanzania Medicinces & Medical Devices Authority

crizotinib pfizer 200 mg capsules, hard

pfizer laboratories limited, kenya - crizotinib - capsules, hard - 200

Crizotinib Pfizer 250 mg Capsules, hard Tanzania - English - Tanzania Medicinces & Medical Devices Authority

crizotinib pfizer 250 mg capsules, hard

pfizer laboratories limited, kenya - crizotinib - capsules, hard - 250

Tofacitinib Pfizer 5 mg Film coated Tablet Tablets Tanzania - English - Tanzania Medicinces & Medical Devices Authority

tofacitinib pfizer 5 mg film coated tablet tablets

pfizer laboratories limited, kenya - tofacitinib citrate - tablets - 5

Champix (Pfizer) New Zealand - English - Medsafe (Medicines Safety Authority)

champix (pfizer)

pfizer new zealand limited - varenicline tartrate 1.71mg equivalent to 1 mg varenicline;  ;   - film coated tablet - 1 mg - active: varenicline tartrate 1.71mg equivalent to 1 mg varenicline     excipient: calcium hydrogen phosphate colloidal silicon dioxide croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue 03b90547 opadry clear ys-2-19114-a - an aid to smoking cessation

Sunitinib Pfizer New Zealand - English - Medsafe (Medicines Safety Authority)

sunitinib pfizer

pfizer new zealand limited - sunitinib malate 16.7mg equivalent to sunitinib 12.5mg;   - capsule - 12.5 mg - active: sunitinib malate 16.7mg equivalent to sunitinib 12.5mg   excipient: croscarmellose sodium gelatin ink iron oxide red magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma

Sunitinib Pfizer New Zealand - English - Medsafe (Medicines Safety Authority)

sunitinib pfizer

pfizer new zealand limited - sunitinib malate 33.4mg equivalent to sunitinib 25mg;   - capsule - 25 mg - active: sunitinib malate 33.4mg equivalent to sunitinib 25mg   excipient: croscarmellose sodium gelatin ink iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma

Sunitinib Pfizer New Zealand - English - Medsafe (Medicines Safety Authority)

sunitinib pfizer

pfizer new zealand limited - sunitinib malate 50.1mg equivalent to sunitinib 37.5mg;   - capsule - 37.5 mg - active: sunitinib malate 50.1mg equivalent to sunitinib 37.5mg   excipient: croscarmellose sodium gelatin ink iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma

Sunitinib Pfizer New Zealand - English - Medsafe (Medicines Safety Authority)

sunitinib pfizer

pfizer new zealand limited - sunitinib malate 66.8mg equivalent to sunitinib 50mg;   - capsule - 50 mg - active: sunitinib malate 66.8mg equivalent to sunitinib 50mg   excipient: croscarmellose sodium gelatin ink iron oxide black iron oxide red iron oxide yellow magnesium stearate mannitol povidone sodium laurilsulfate titanium dioxide - treatment of advanced renal cell carcinoma

Exemestane Pfizer Australia - English - Department of Health (Therapeutic Goods Administration)

exemestane pfizer

pfizer australia pty ltd - exemestane -

Heparinised Saline (Pfizer) New Zealand - English - Medsafe (Medicines Safety Authority)

heparinised saline (pfizer)

pfizer new zealand limited - heparin sodium 10 iu/ml - solution for injection - 50 iu/5ml - active: heparin sodium 10 iu/ml excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection